Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
DNALite Therapeutics
company
About
DNALite Therapeutics is an early-stage preclinical biotechnology company.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $0.96M
- Industries
- Biotechnology,Genetics,Health Care
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
DNALite Therapeutics is an early-stage preclinical biotechnology company committed to bringing the next generation of drugs to the gastrointestinal tract. It develops oral lipid nanoparticle technology to deliver mRNA and pDNA into the intestine using the oral route of administration. Its drug aims to use the intestinal tract to secrete proteins into the bloodstream turning any protein biologic into an oral drug.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$2.69M
DNALite Therapeutics has raised a total of
$2.69M
in funding over 2 rounds. Their latest funding was raised on
Dec 28, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 28, 2021 | Grant | $0.96M | 1 |
National Science Foundation
|
— | Detail |
| Jan 31, 2019 | Grant | $224.68K | 1 |
National Science Foundation
|
— | Detail |
| Aug 8, 2018 | Seed | $1.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
DNALite Therapeutics is funded by 2 investors.
National Science Foundation
and SVE Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
